Skip to main content
Log in

Bedeutung für Prognose und Therapie

Aktuelles zur molekularen Klassifizierung von Endometriumkarzinomen

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. de Boer SM et al. Lancet Oncol. 2018;19:295-309

  2. Leon-Castillo A et al. J Clin Oncol. 2020;38:3388-97

  3. Raffone A et al. Gynecol Oncol. 2019;155:374-83

  4. Marnitz S et al. Strahlenther Onkol. 2020;196:963-72

  5. Marnitz S et al. Cancers (Basel). 2020;12(9):2577

  6. Creutzberg CL et al. Int J Radiat Oncol Biol Phys. 2011;81:e631-e638

  7. Ko E et al. Gynecol Oncol. 2011;121:S100-S100

  8. Wortman BG et al. Br J Cancer. 2011;119:1067-74

  9. Randall ME et al. J Clin Oncol. 2019;37:1810-8

  10. Matei D et al. N Engl J Med. 2019;380:2317-26

  11. Marnitz S et al. Strahlenther Onkol. 2018;194(11):965-74

  12. Waltar T, Marnitz S. Strahlenther Onkol. 2020;196:410-3

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marnitz, S., Schömig-Markiefka, B. Aktuelles zur molekularen Klassifizierung von Endometriumkarzinomen. InFo Hämatol Onkol 24, 33–34 (2021). https://doi.org/10.1007/s15004-021-8783-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8783-7

Navigation